Company Overview - Zhejiang Yongtai Technology Co., Ltd. was established in 1999 and listed in 2009, headquartered in Taizhou, Zhejiang Province, specializing in fluorine fine chemicals manufacturing [2][3] - The company covers new materials (lithium battery and fluorinated liquid materials), pharmaceuticals, plant protection, and trade, with a comprehensive product range across the upstream and downstream supply chain [2][3] Performance and Financials - In 2024, the company achieved a revenue of CNY 458,939.78 million, a year-on-year increase of 11.18%, with a net profit loss reduced by 36.26% [4] - The lithium battery materials segment showed significant improvement with a gross margin increase of 23.07 percentage points; the plant protection segment's revenue grew by 91.79% [4] - In Q1 2025, the company reported a revenue of CNY 105,995.92 million and a net profit of CNY 1,057.75 million [4] Business Segments Trade Segment - The trade segment, led by subsidiary Shanghai Nonghui, focuses on the sale of pesticide raw materials and formulations, holding over 1,500 overseas pesticide registration certificates [5] Plant Protection Segment - The growth in the plant protection business was driven by three factors: market recovery post-inventory adjustment, new production lines coming online, and proactive customer expansion [6][7] Lithium Battery Technology - The company prioritizes the development of medium and long-term lithium battery technology, enhancing collaboration with industry partners for application research [8] - The commercialization timeline for this technology remains uncertain, dependent on R&D progress and market conditions [9] Fluorinated Liquid Products - The fluorinated liquid business has established a small-scale order base, with plans for rapid growth through product optimization and market expansion [10] - The market for fluorinated liquids is expanding due to advancements in AI, high-performance computing, and semiconductor manufacturing, though challenges remain [11] Future Growth Strategies - Profit growth will be driven by expanding lithium materials capacity, stable demand in pharmaceuticals, global expansion in plant protection, and breakthroughs in new businesses like fluorinated liquids [12] - The company is exploring solid-state battery technology, maintaining communication with industry partners to adapt to market needs [12] Pharmaceutical Business Development - The pharmaceutical segment will focus on high-value formulations, leveraging procurement opportunities to penetrate the domestic market, and enhancing market development capabilities through specialized teams [13] Financing Plans - Currently, there are no plans for additional financing; future decisions will be based on project progress and funding needs [15]

跟踪芯片领域动态 +订阅 台积电：关税将"杀死"亚利桑那州1650亿美元先进制造投资 金十数据5月23日讯，据美媒PCMag报道，台积电(TSM.N)警告称， 美国拟对外国制造的芯片加征关 税，可能危及其在亚利桑那州高达1650亿美元的先进半导体制造设施投资。该公司在提交给美国商务部 的公开评论中指出， 关税导致的需求下降可能影响其美国业务的可行性。台积电强调，其亚利桑那晶 圆厂最终将占该公司全球尖端2纳米及更先进芯片产能的30%左右，足以满足美国的预期需求。这家芯 片制造商还证实，已开始在该州建设第三座晶圆厂，该厂初期将生产2纳米芯片，后期将采用其下一代 A16工艺技术。 ...

如果您希望可以时常见面，欢迎标星收藏哦~ 来源：内容来自经济日报，谢谢。 台积电（2330）将于6月3日举行股东常会，最新出炉的股东会年报中，旗下海外布局去年损益状 况全都露，其中，美国亚利桑那州新厂去年认列亏损近143亿元，是最烧钱的海外厂区；日本、欧 洲布局也分别亏损逾43亿元及5亿多元；大陆事业则大放异彩，南京厂相关事业去年大赚近260亿 元。 台积电宣布挥军「美国制造」后，2021年、2022年与2023年股东会年报中，已陆续揭露亚利桑那 子公司损益，分别亏损48.1亿元、94.3亿元与109.24亿元，去年则亏损142.98亿元，是美国新厂成 立来最大亏损，换算台积电亚历桑那厂去年第4季开始量产之前，过去四年间已累亏逾394亿元。 台积电日前已宣布扩大投资美国千亿美元，美国总投资金额将达1,650亿美元。 台积电董事长魏哲家上周于法说会中表示，投入亚利桑那州厂建置，完全是基于客户的需求，未来 在相关计画建设完成后，其2纳米及更先进制程产能将有约30％来自亚利桑那州晶圆厂，得而在美 国形成一个独立的先进半导体制造聚落。 除了原先就已规划在亚利桑那州建置三座晶圆厂，台积电新增投资包含另外再兴建三座新晶圆 ...